These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32701261)

  • 21. Lipid composition dictates serum stability of reconstituted high-density lipoproteins: implications for in vivo applications.
    Gilmore SF; Carpenter TS; Ingólfsson HI; Peters SKG; Henderson PT; Blanchette CD; Fischer NO
    Nanoscale; 2018 Apr; 10(16):7420-7430. PubMed ID: 29564446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of disulfide-stabilized Fabs for targeting of antibody-directed nanotherapeutics.
    Geddie ML; Kirpotin DB; Kohli N; Kornaga T; Boll B; Razlog M; Drummond DC; Lugovskoy AA
    MAbs; 2022; 14(1):2083466. PubMed ID: 35708974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs.
    Forte N; Livanos M; Miranda E; Morais M; Yang X; Rajkumar VS; Chester KA; Chudasama V; Baker JR
    Bioconjug Chem; 2018 Feb; 29(2):486-492. PubMed ID: 29384367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of site-specific ScFv PEGylation for tumor-targeting pharmaceuticals.
    Natarajan A; Xiong CY; Albrecht H; DeNardo GL; DeNardo SJ
    Bioconjug Chem; 2005; 16(1):113-21. PubMed ID: 15656582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of
    Weilhammer DR; Dunkle AD; Boone T; Gilmore SF; Khemmani M; Peters SKG; Hoeprich PD; Fischer NO; Blanchette CD; Driks A; Rasley A
    Front Immunol; 2020; 11():1264. PubMed ID: 32714323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific Conjugation of the Hinge Region for Homogeneous Preparation of Antibody Fragment-Drug Conjugate: A Case Study for Doxorubicin-PEG-anti-CD20 Fab' Synthesis.
    Zhou Z; Zhang J; Zhang Y; Ma G; Su Z
    Bioconjug Chem; 2016 Jan; 27(1):238-46. PubMed ID: 26700095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mild and efficient conjugation of rabbit Fab' and horseradish peroxidase using a maleimide compound and its use for enzyme immunoassay.
    Yoshitake S; Imagawa M; Ishikawa E; Niitsu Y; Urushizaki I; Nishiura M; Kanazawa R; Kurosaki H; Tachibana S; Nakazawa N; Ogawa H
    J Biochem; 1982 Nov; 92(5):1413-24. PubMed ID: 6759501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The design and evaluation of a novel targeted drug delivery system using cationic emulsion-antibody conjugates.
    Goldstein D; Nassar T; Lambert G; Kadouche J; Benita S
    J Control Release; 2005 Nov; 108(2-3):418-32. PubMed ID: 16226821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fab-Nanolipoprotein Conjugate Causes Vitreous Opacity and Cataracts Following a Single Intravitreal Administration in New Zealand White Rabbits.
    Tassew NG; Laing ST; Shatz W; Crowell SR; Loyet KM; Schuetz C; Blanchette C
    Toxicol Pathol; 2021 Apr; 49(3):647-655. PubMed ID: 33733956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge.
    Weilhammer DR; Blanchette CD; Fischer NO; Alam S; Loots GG; Corzett M; Thomas C; Lychak C; Dunkle AD; Ruitenberg JJ; Ghanekar SA; Sant AJ; Rasley A
    Biomaterials; 2013 Dec; 34(38):10305-18. PubMed ID: 24075406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fab-PEG-Fab as a potential antibody mimetic.
    Khalili H; Godwin A; Choi JW; Lever R; Khaw PT; Brocchini S
    Bioconjug Chem; 2013 Nov; 24(11):1870-82. PubMed ID: 24073593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterizing diffusion dynamics of a membrane protein associated with nanolipoproteins using fluorescence correlation spectroscopy.
    Gao T; Blanchette CD; He W; Bourguet F; Ly S; Katzen F; Kudlicki WA; Henderson PT; Laurence TA; Huser T; Coleman MA
    Protein Sci; 2011 Feb; 20(2):437-47. PubMed ID: 21280134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and biological evaluation of polymerizable antibody Fab' fragment targeted polymeric drug delivery system.
    Lu ZR; Shiah JG; Kopecková P; Kopecek J
    J Control Release; 2001 Jul; 74(1-3):263-8. PubMed ID: 11489505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
    Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
    Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved procedure for the conjugation of rabbit IgG and Fab' antibodies with beta-D-galactosidase from Escherichia coli using N,N'-o-phenylenedimaleimide.
    Hamaguchi Y; Yoshitake S; Ishikawa E; Endo Y; Ohtaki S
    J Biochem; 1979 May; 85(5):1289-300. PubMed ID: 109428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colocalized delivery of adjuvant and antigen using nanolipoprotein particles enhances the immune response to recombinant antigens.
    Fischer NO; Rasley A; Corzett M; Hwang MH; Hoeprich PD; Blanchette CD
    J Am Chem Soc; 2013 Feb; 135(6):2044-7. PubMed ID: 23331082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conjugation of acetylcholine receptor-protecting Fab fragments with polyethylene glycol results in a prolonged half-life in the circulation and reduced immunogenicity.
    Trakas N; Tzartos SJ
    J Neuroimmunol; 2001 Nov; 120(1-2):42-9. PubMed ID: 11694318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells.
    Merdan T; Callahan J; Petersen H; Kunath K; Bakowsky U; Kopecková P; Kissel T; Kopecek J
    Bioconjug Chem; 2003; 14(5):989-96. PubMed ID: 13129403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative antibody Fab' fragment PEGylation strategies: combination of strong reducing agents, disruption of the interchain disulphide bond and disulphide engineering.
    Humphreys DP; Heywood SP; Henry A; Ait-Lhadj L; Antoniw P; Palframan R; Greenslade KJ; Carrington B; Reeks DG; Bowering LC; West S; Brand HA
    Protein Eng Des Sel; 2007 May; 20(5):227-34. PubMed ID: 17452434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectroscopic Characterization of Structural Changes in Membrane Scaffold Proteins Entrapped within Mesoporous Silica Gel Monoliths.
    Zeno WF; Hilt S; Risbud SH; Voss JC; Longo ML
    ACS Appl Mater Interfaces; 2015 Apr; 7(16):8640-9. PubMed ID: 25849085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.